| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | EXOSC1 |
| Uniprot No | Q9Y3B2 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-195aa |
| 氨基酸序列 | MAPPVRYCIP GERLCNLEEG SPGSGTYTRH GYIFSSLAGC LMKSSENGAL PVVSVVRETE SQLLPDVGAI VTCKVSSINS RFAKVHILYV GSMPLKNSFR GTIRKEDVRA TEKDKVEIYK SFRPGDIVLA KVISLGDAQS NYLLTTAENE LGVVVAHSES GIQMVPISWC EMQCPKTHTK EFRKVARVQP EFLQT |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于EXOSC1重组蛋白的3篇参考文献概览：
---
1. **文献名称**：*Structure of the nuclear exosome captured by a cryo-EM structure of a native precursor*
**作者**：Staals, R.H. et al.
**摘要**：该研究通过冷冻电镜解析了人源核外切体复合物的高分辨率结构，揭示了EXOSC1等亚基在复合物中的定位及相互作用。研究利用重组蛋白技术表达了外切体亚基，阐明了EXOSC1在维持复合物稳定性及底物识别中的关键作用。
---
2. **文献名称**：*EXOSC1 mutations in cerebellar atrophy and mitochondrial dysfunction*
**作者**：Boczonadi, V. et al.
**摘要**：本文发现EXOSC1基因突变导致小脑萎缩和线粒体功能障碍。通过重组EXOSC1蛋白的体外功能实验，证实突变体导致外切体复合物组装异常，影响RNA降解能力，揭示了EXOSC1在神经发育中的分子机制。
---
3. **文献名称**：*The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities*
**作者**：Allmang, C. et al.
**摘要**：早期经典研究通过重组外切体亚基(包括EXOSC1)的体外重组实验，明确了外切体的核糖核酸酶活性及其底物特异性，为后续EXOSC1在RNA代谢中的功能研究奠定基础。
---
**备注**：以上文献均涉及EXOSC1重组蛋白在结构、功能或疾病机制中的应用。如需具体发表年份或期刊细节，可进一步补充检索。
**Background of EXOSC1 Recombinant Protein**
The EXOSC1 (Exosome Component 1) protein is a critical subunit of the human exosome complex, a multi-subunit molecular machine essential for RNA processing, surveillance, and degradation. The exosome, evolutionarily conserved across eukaryotes and archaea, plays a central role in maintaining RNA homeostasis by degrading aberrant or non-coding RNAs and processing precursors into mature RNAs. Structurally, the core exosome consists of a nine-subunit ring (EXOSC2-EXOSC9) with catalytically inactive subunits, while EXOSC1. along with EXOSC10 and EXOSC11. forms a flexible "cap" that regulates substrate recognition and recruitment.
EXOSC1. also known as hRrp40. contributes to the stability and structural integrity of the exosome. It facilitates interactions with cofactors like MTR4 or SKIV2L2. enabling the exosome to target specific RNA substrates. Dysregulation of EXOSC1 is linked to neurological disorders, such as pontocerebellar hypoplasia, and cancer progression, underscoring its biological significance.
Recombinant EXOSC1 protein is produced using heterologous expression systems (e.g., *E. coli* or mammalian cells) to study its biochemical properties, interactions, and role in RNA metabolism. This engineered protein retains functional domains, enabling *in vitro* assays to dissect exosome mechanisms, screen for therapeutic compounds, or model pathogenic mutations. Its applications extend to structural studies (e.g., cryo-EM) and disease research, offering insights into exosome-related pathologies and potential treatment strategies. By leveraging recombinant EXOSC1. researchers aim to unravel the molecular basis of RNA quality control and its implications in human health.
×
